[{"data":1,"prerenderedAt":76},["ShallowReactive",2],{"guideline:8":3,"guideline-cats":21},{"code":4,"msg":5,"data":6,"success":19,"time":20},200,"操作成功",{"guidelineId":7,"code":8,"nameZh":9,"nameEn":10,"studyType":11,"summaryZh":12,"summaryEn":13,"versionZh":14,"versionEn":14,"fileUrlZh":14,"fileUrlEn":14,"externalUrl":15,"logoUrl":14,"releaseState":16,"sortNum":17,"status":18},8,"TIDieR for Acupuncture","TIDieR(针刺干预措施与可重复性报告规范)","TIDieR(The Template for Intervention Description and Replication checklist for Acupuncture)","intervention","TIDieR‑A 是通用TIDieR报告规范的针刺专属扩展版，遵循 EQUATOR 协作网方法学规范开发。立足针刺作为复杂干预的特征，统一规范针刺干预理论依据、穴位选择、针刺操作参数、对照设计等针刺相关安全性要素的报告要求，适用于各类针刺相关临床研究，提升针刺干预描述完整性、可复现性。","TIDieR‑A is an acupuncture‑specific extension of the generic TIDieR Statement, developed following methodological standards from the EQUATOR Network. Tailored to acupuncture as a complex intervention, it standardizes reporting requirements for acupuncture rationale, acupoint selection, needling parameters, comparator design and acupuncture‑related safety concerns. Applicable to diverse types of acupuncture‑related clinical studies, it improves completeness and replicability of acupuncture intervention descriptions.","","https:\u002F\u002Fwww.equator-network.org\u002Flibrary\u002Freporting-guidelines-under-development\u002Freporting-guidelines-under-development-for-clinical-trials\u002F#TIDIER-A","open",7,"0",true,"2026-10-22T12:31:01.296643",{"code":4,"msg":5,"data":22,"success":19,"time":75},[23,30,36,42,48,54,60,65,70],{"iconPaths":24,"nameZh":25,"catId":26,"status":18,"catKey":27,"nameEn":28,"sortNum":29},"M4 5h16M4 5v14M4 19h16\nM8 15l3-4 2 2 3-5","随机对照试验",1,"rct","RCT",0,{"iconPaths":31,"nameZh":32,"catId":33,"status":18,"catKey":34,"nameEn":35,"sortNum":26},"M8 3h6l4 4v14H6V5\nM8 3v4H4\nM9 13h6M9 17h4","试验方案",2,"protocol","Protocol",{"iconPaths":37,"nameZh":38,"catId":39,"status":18,"catKey":40,"nameEn":41,"sortNum":33},"M12 3v18\nM5 8l7-5 7 5\nM5 8v8l7 5 7-5V8","系统综述",3,"sr","Reviews",{"iconPaths":43,"nameZh":44,"catId":45,"status":18,"catKey":46,"nameEn":47,"sortNum":39},"M7 3h7l4 4v14H6V4\nM14 3v4h4\nM12 11v6M9 14h6","病例报告",4,"case","Case report",{"iconPaths":49,"nameZh":50,"catId":51,"status":18,"catKey":52,"nameEn":53,"sortNum":45},"M12 3l8 4v6c0 4.5-3.2 7-8 8-4.8-1-8-3.5-8-8V7z\nM9 12l2 2 4-4","实践指南",5,"guideline","Guideline",{"iconPaths":55,"nameZh":56,"catId":57,"status":18,"catKey":58,"nameEn":59,"sortNum":51},"M4 20c0-3 2-5 4-5s4 2 4 5\nM15 8c2 0 4 1.5 4 4s-2 4-4 4\nM17 12h.01","动物实验",6,"animal","Animal",{"iconPaths":61,"nameZh":62,"catId":17,"status":18,"catKey":63,"nameEn":64,"sortNum":57},"M4 5h16M4 5v14M4 19h16\nM8 16l3-3 2 2 3-4","非随机对照试验","nrct","Non-randomised trial",{"iconPaths":66,"nameZh":67,"catId":7,"status":18,"catKey":68,"nameEn":69,"sortNum":17},"M2 12s3.5-6 10-6 10 6 10 6-3.5 6-10 6-10-6-10-6z\nM12 9.5a2.5 2.5 0 1 0 0 5 2.5 2.5 0 0 0 0-5z","观察性研究","obs","Observational study",{"iconPaths":71,"nameZh":72,"catId":73,"status":18,"catKey":11,"nameEn":74,"sortNum":7},"M9 3h6v4h4v6h-4v4H9v-4H5V7h4V3z M4 21h16","干预措施",9,"Intervention","2026-10-22T12:31:01.418523",1792643460895]